new glp 1 drugs 2025 project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our Weight-loss drugs such as Ozempic
Description
The big question is, which is the best choice
Management of hyperglycemia in type 2 diabetes, 2022
For clinical and manufacturing leaders, that means developing a coordinated manufacturing network strategy that is reliable across regional disruptions, not relying on single suppliers, and balancing the manufacturing load across locations
[174] An observational study on people with obesity and type 2 diabetes and heart failure with preserved ejection fraction, semaglutide had about a 42% lower risk of hospitalization for heart failure and all-cause death combined compared with sitagliptin
It is important to remember that in this trial everyone was blind
Cost alone does not determine value, though
